Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Short SellingSee which listed companies have disclosed short interest
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Transcripts

Read transcripts of webcasts and audiocasts

Transcripts

Read transcripts of webcasts and audiocasts

All regions
Sweden
Finland
Denmark
Norway
Latest
Trending
Followed

Trelleborg, Audiocast with teleconference, Q2'24

By Inderes7/18/2024, 1:00 PM
Trelleborg

Disclaimer: This is a machine-generated transcript and may contain inaccuracies.

Peter Nilsson
00:00 - 11:26

Thank you. And welcome to all of you to this interim call for Trelleborg covering quarter two, 2024. We will refer to the slides. They are on our homepage as usual, and we'll use them as guidance throughout the call. As usual, I'm going to start with Peter and give you some overall highlights, supported by Fredrik Nilsson, our CFO. We're going to guide you through the financials. Then I'm going to sum up with some comments on the running quarter. And then of course, at the end, Also as usual, open up for a Q&A session. So once again, back to the slides, presented on the homepage and turning there to page two. Agenda slide. Starting off with some highlights, some comments on our business areas. Then Fredrik will guide us with some comments on the financials and then finish off with the summary and some comments on the running quarter, and then open up for Q&A. Turning to page three and heading for our report. Organic growth and improved margins. We are back to positive territory, although slim, but nevertheless a positive territory in terms of organic growth this quarter. And we also continue to deliver an improved margin year on year. So that is, let's say, the headline for the report, and in more detail, I mean sales were 8.7 billion, basically in line with last year. We also have some discontinued operations which explain this difference between the organically positive and the flat sales, uh, M&A, which was a certain retailer guiding us as a discontinued operation. We sold off some operations a year ago, and that is then impacting the overall sales results. Currency did not impact sales this quarter, a change from before. EBITA just shy of 1.6 billion, corresponding to a margin of 18.4%. This 1.6 billion is actually the highest EBITA to date we have had. We have delivered a slightly higher margin in individual quarters before, but nevertheless, in terms of operational performance, definitely one of the best quarters ever for Trelleborg in this structure. Items impacting comparability are in line with our guidance. And Fredrik commented that it was a little over 100 million in the quarter. Cash flow was 1.2 billion, slightly lower compared to a very good quarter a year ago. Fredrik will comment on it as well. This is a normal, let's say, development phase. And the cash conversion on a rolling 12 is still at a solid 18%. We also note with satisfaction that we have completed two acquisitions in the quarter: MNE Group in Korea, which is strengthening us in terms of sales for semiconductor manufacturing. And then also BP-Tech Group, a Finnish company, which is supplementing our presence in terms of the rehabilitation of pipes. As of yesterday, we are now the full owners of Baron Group. This was an important acquisition for us to discuss and comment on, crucial for us to strengthen our position within our medical business area. Once again, I will comment more on that later. Turning to page four regarding organic sales per geography, as you see, Asia is growing by 4%, North and South America also by 3%, while Europe is down by 1%. I mean, this is a little bit distorted, as you said, with Asia solid in both North and South America benefiting from high product sales, while Europe was impacted by slightly lower product sales. So, the underlying performance is more flattish if you compare it between Europe and North America. Nevertheless, these are the actual reported figures for the quarter. Turning then to page five, regarding the agenda slide again, and commenting on the business areas. Uh, quickly turning to page six and commenting on industrial solutions, organic sales were slightly negative, supported by a positive percentage point from M&A. Um, not much change compared to before. Residential construction in the industrial segments continues to be on the weaker side, and sales in Industrial Solutions have been supported by strong product sales, especially linked to LNG and also some renewables. Automotive sales continue to grow, and we know that Asia is especially strong. All in all, well-managed business. And I mean, on the basis of this slightly negative sales development, we still managed to deliver a slim uptick in EBITDA, which is then creating an uptick of 0.4%, but nevertheless, 0.4 percentage points up on margin, continued solid development in industrial solutions. As already mentioned, we are pleased to note that we have once again delivered a good bolt-on acquisition in the pipe rehabilitation business. Turning to page seven, on Medical Solutions, back to organic growth. I mean, you say we were a little bit positively surprised here at the end of the quarter, especially the North American market picked up and we were able to actually sell more than we had anticipated at the beginning of the quarter. And we also note, overall, that this inventory adjustment that has been hurting us a little bit for quite a few quarters now, we see finally that it is easing off. We have to be careful with the firm conclusions on this. But this is what we see in the figures at the moment. We also know that Audi sales were up. We are still down a little bit. This is still in the creation mode of the new BA. We have been adding some costs into the structure, and we will also continue to invest in specific segments where we see long-term potential, both in growth and profitability. And then, of course, the big thing actually happened after the quarter when we finalized the Baron Group acquisition. So turning to page eight and some comments on that. Baron is a major stepping stone for us here to create a fully global business. I mean, we can now say that we are probably the most global. We are the most global company in terms of this segment, which we are focusing basically on liquid silicone for medical applications. With this acquisition of Baron Group, we will gain access to very good manufacturing facilities in Asia and Australia. Um, and this is something now we're looking forward to, continuing to develop and create a structure within this medical area that will benefit us long-term in our journey towards, let's say, €500 million in sales and margins in line with our guidance of 20%. So we believe we are on a good track with that development and we are putting the different pieces in place now in order to push further in that direction. So then returning to page nine, I'd like to comment on the sealing solutions and the return to organic growth. The same heading applies to medical solutions: solid organic growth in the quarter. Also benefiting from M&A, which supports us with a couple of percentage points in the quarter. Um, you still note, although the secondary industry is still declining in most markets, it's likely better in Asia, being flattish there, whereas we see overall challenges persisting in the yellow industry segments. And I mean linking a little to off-highway construction equipment, those kinds of products are still hurting us a bit. But although we do see the light at the end of the tunnel in that segment as well, deliveries in the automotive industry have increased in all regions. I mean, we are benefiting from good growth in our focus segments in the automotive sector, and this is basically happening all across the world for sealing solutions. And on top of that, there's also very strong continued development in aerospace with good order intake and deliveries. Uh, overall, EBITA is improving but not in line with sales. And we continue as we've been guided here. We continue to invest in some market segments where we believe we can perform better and will create a stronger footprint for us for the long-term benefits. We continue to invest and build a better business for the long-term in order to achieve our long-term targets, both in terms of growth and profit. And as part of that, we are also satisfied to announce the finalization of the acquisition of MNE Group in Korea in the quarter, which creates a new base for us, especially targeting the semiconductor manufacturing, which is an area we believe holds good prospects for us going forward. And turning to page ten, some comments on sustainability. Um, CO2 emissions continue to develop very nicely. We are, as you can see here, seeing year-on-year substantial improvements. Turning to page 11, you can see also, let's say one of the major drivers for this is that we are substantially increasing the share of renewable and emission-free electricity as part of our electricity consumption. So overall, a very good development in this area. Um, back to page 12 for the financial agenda. And then I'll hand over to Fredrik to guide us through page 13 and onwards. Thank you Peter. Let's start with the sales development.

Fredrik Nilsson
11:27 - 14:44

Organic sales were up 1% in the quarter. Looking at the business areas, as Peter mentioned, Industrial Solutions declined by 1%, while Medical Solutions reported a growth of 2% and Sealing Solutions grew by 5%. Reported net sales were on par with last year. Organic sales, as I said, were at 1%. But structural changes reduced the sales by 1% and currency impact was net unchanged. Moving on to page 14 showing the historical sales growth. And as you can see, the second quarter was below our sales target. That is 8%. But the positive here is that we are back to organic growth. Moving on to page 15, showing the quarterly sales on a rolling 12 months for continuing operations. As I said, sales were 8.7 billion in the quarter and at a rolling 12 month basis at 33.8 billion. Moving on to page 16 and looking at the EBITA development and also the margin development. We have an EBITA in the quart.User of $1,599,000,000, which was an increase by two percentage points. And as Peter also said, it's the best ever for a single quarter. We saw profit growth for both our two largest business areas: Industrial Solutions and Sealing Solutions, and a minor decrease for Medical Solutions. In the results, there was a minor translation difference of $18 million in the quarter. Looking at the margin, there was good improvement from 18% up to 18.4%. And this is despite, as we initially had some acquisitions with lower margins. And we also continue to invest in the organization in some fast-growing market segments. Looking at page 17, the rolling 12 months EBITA actually amounts to exactly $6 billion, with a margin of 17.7%. And as you can see in the chart, the EBITA growth over the last 12 months has been 4%. Moving on to page 18. Going into more details in the income statement. We have items affecting comparability in the quarter of $111 million, which is entirely related to restructuring costs for adjusting our cost base. Looking into the financial net, you can see -$63 million in the quarter versus $140 million last year. And I would like to highlight here that last year included a financial gain of $218 million, which was attributable to some interest rate swaps that we closed when we divested. The tire operations.

Unknown 1
14:46 - 14:46

Tax.

Fredrik Nilsson
14:46 - 18:57

Rate for the quarter amounted to 24%, which is slightly below our underlying tax rate of 25%. Moving on to page 19, earnings per share. If we look at earnings per share, excluding items affecting comparability, it's $49.25 versus $4.71 in Q2 last year. But again, the impact we have here also from the closing of the interest rate swap had an impact of $173 million after tax, which translated into earnings per share is $0.68 in the two-two numbers for 2023. Adjusted for that, we have an EPS improvement of 11% year-over-year. And then if you're looking at the group, including the divested businesses, then you can see that we have an EPS of 4.14 versus 21.67. And the reason here is, of course, we had a huge impact from the discontinued operations last year, also including the capital gains related to the divestment of the tire and the printing blanket business. Moving on to page 20. And cash flow. And as you can see here, we have a cash flow of $1,190,000,000. In the quarter. And we have a positive impact from EBITA of $59 million in the quarter. And then you can see that we have somewhat higher working capital in the quarter. And that was related to that we have seen some increased demand in certain segments, which has tied up a little bit more inventory to secure supply to our customers. And then also a little bit higher CapEx, which is in line with our previous guidance, that is, we have ongoing greenfield projects underway in 2024, just as we did in 2023. Moving on, looking at the cash conversion, it's actually unchanged compared to a year ago. We have good cash conversion of 88%, and that is despite seeing higher CapEx levels. Moving on to page 22. Looking at the gearing and leverage development, we are now actually back to a net debt position at the end of the quarter of 1,981,000,000. During this quarter, I would like to highlight that we bought back shares worth 937 million. And we have also paid out dividends totaling 1,617,000,000. So the debt-to-equity ratio was 5%. And net debt in relation to EBITDA was 0.3. So our balance sheet remains very strong. Looking at page 23, return on capital employed was 12.7% for the quarter. Our capital employed was impacted by acquisitions with initially lower returns. Moving on to the guidelines for the full year, CapEx is 1.6 billion, unchanged. Restructuring costs 300 million, a small increase of 50 million from the last quarter. So, we're now going for 300 million amortization of intangible assets, 500 million. This is excluding the Baron acquisition. That being said, we need to come back with more information, uh, when we have them calculated. The underlying tax rate is 25%. And with that I would like to hand the microphone back to Peter.

Peter Nilsson
19:01 - 21:45

Thank you. Thank you. Fredrik. Uh, agenda slide again, page 25. And then quickly turning to summary and outlook. Uh, page 26. We already see common organic growth and improved margins. We believe this has been a solid quarter. We are back in growth territory organically, and we have also managed to improve the business in terms of margin. With solid cash flows, albeit lower than a year ago, we still maintain very good levels on a rolling 12-month basis. And we are pleased this quarter that we managed to make two very nice bolt-on acquisitions: one in Korea strengthening semiconductor manufacturing and another in Finland with more or less a global presence focusing on high-quality sealings for the rehabilitation of pipes. So it's been a good addition for us. And then, of course, also very importantly, after the end of the quarter, we completed the Baron acquisition, which is now being integrated as of yesterday. And we will see these figures reflected in the next quarter, which will, of course, be noted when we report our Q3 results. So that's one. And then, page 27 outlook. We believe we have a solid order book with slight continued improvements, maintaining high levels in certain areas. We talk about the product business, we talk about aerospace, we talk about the improvement in the medical sector. And we see, let's say, a slight improvement kicking in also in some industrial segments, although there are continued challenges in residential and construction and some of the more distribution-related sales; industrial sales are down. Overall, we feel confident that we are guiding for a slightly higher demand for us in Q3 compared to Q2. Um, of course we still have this, let's say, comment. Additionally, we are still exposed to a somewhat turbulent political situation. Unfortunately, we need to add this also to our comment. I mean, it's not an increased risk, but nevertheless, it's still around and we don't really know what's happening. So that is why we're adding that back to the agenda and quickly moving to the Q&A. So, to page 29, and opening up for Q&A. Welcome to the presentation of Trelleborg's interim report for the second quarter, April to June 2024.

Operator
21:52 - 22:12

If you wish to ask a question, please dial pound key five on your telephone keypad to enter the queue. If you wish to withdraw your question, please dial the pound key six on your telephone keypad. The next question comes from Klaas Berge, calling from the city. Hello everyone, thank you for joining us today for the presentation of Trelleborg's interim report for Q2 2024.

Peter Nilsson
22:16 - 22:18

Thank you. Hi, Peter and Fredrik Nilsson.

Unknown 2
22:19 - 22:54

My first question is on the guidance which is sequential, and you're saying it's somewhat higher. So, should we expect this to translate into somewhat higher year-over-year growth as well? Around 2 to 3%. That's what I get, at least, when I try to adjust for seasonality. And could you help us, Peter? Where do you see the bigger improvement quarter on quarter? We've talked a lot about North America and the stock at the OEM level being a drag, I think, for four quarters versus the normal two. Is that now leveling off for you, or is it mainly in China where you see improvements into the third quarter, and do you also have a lower level of stock in Medical? That should help some clarity. That would be great. Thank you.

Peter Nilsson
22:55 - 24:32

I understand that we don't need the guide for the video. Let's say organic growth. We are gradually getting better, let's say it's a slight improvement. This means, of course, performance is expected to improve in Q3 compared to Q2 on a year-over-year basis. I mean, that is the basic guidance. And then, if we don't want to divulge any more, we simply say it's going to be slightly better. Of course, it's not a dramatic change. We believe it to be slightly better. And that's coming from a fairly wide range of activities; we still continue to see strong performance in aerospace, oil, gas, and LNG sectors. We still feel the automotive sector is holding up surprisingly well. We also see that water intake in that area remains good. And we know also that the downturns in construction and some of these more consumption-oriented industrials are not due to a further decline; we foresee an end to the destocking in the medical area. And we also note that there is maybe where we have more uncertainty in business. And that is kind of the end of this. What you say about inventory reduction in more industrial component businesses. And that is where we see order intake is getting slightly better. But there we have to be open and say there is still some uncertainty. Uncertainty about how the recovery will unfold there. But overall, when we put everything together, we feel confident about this slightly raised guidance.

Unknown 2
24:34 - 25:12

Thank Grant you. Peter. Then my second question is on TMS and the significant improvement here in June. So is this sort of a complete upturn in stocks? Or do you think that this can continue into the third quarter? And also on Baron Group, which is now finalized. Obviously the margin here for TMS, before Baron Group, is not really following through as I thought, despite the better organic growth, you're obviously still investing in growth, but you are confident that you can reach a 20% margin through the second half, including with Baron Group, if you keep investing in growth into the second half. That would suggest to me that Baron Group has a great margin, maybe even 25%, just to make the math work. If you can comment on that. Thank you.

Peter Nilsson
25:13 - 27:34

Yeah, it is talked about how the stock is still volatile. The volatility is high here. I honestly thought, based on what we said here, we would be surprised by the uptick here in June, that the uptake would be bigger. And of course, we don't feel fully confident that that's going to continue. But we also have to note that the comparison is getting easier here in the second year. And so we feel, in terms of year-on-year, we feel confident that the volatility will be less than a year ago. And with Baron Group, there are some synergies in this. There are some takeaways from the integration of these. We're going to create potential benefits for ourselves. I don't want to say we have said anything including Baron Group. Once that is integrated and done, we then feel confident to proceed. Let's say 20 plus or minus—it's hard to provide an exact guide of 20.0, but it is expected to be close to 20. And that is also exactly dependent. Our integrated approach has been vital, and of course, we have been developing the organization within Medical Solutions in order to effectively integrate this balance. So, we are carrying a few extra costs in the quarter in order to be fully ready to take this on now, as it's being fully owned by us. So, of course, we are taking a bit of a long-term view, and I understand that you are focusing on the upcoming quarters. But what is more, we're going to get up to a run rate of 20 in the next few quarters, whether that will be exactly in Q3 and Q4, we can give firm guidance. We believe that. And we firmly believe that this will be integrated. And that's, of course, getting them on board with the modern imperatives of sustainability. And I mean, that is something which would be beneficial for us, but it also needs to be integrated in a good way, which we have been preparing for for some time. And we feel confident that that's going to happen. And then of course, gearing up this total business for continued good organic growth, I mean, that is really what we are looking for. We are not targeting, let's say, margin for the next quarter. We are targeting a run rate here for the next six to twelve months.

Unknown 2
27:35 - 27:43

No, the reason why is the synergies typically come a bit later, versus at the time of the exact integration. So, yeah, but okay, you sound.

Peter Nilsson
27:44 - 27:54

Some immediate synergies. I mean, in terms of purchasing and for some operational assets. And that is why we feel confident that this is going to deliver good benefits.

Unknown 1
27:54 - 27:55

Thank you.

Operator
28:04 - 28:10

The next question comes from Douglas Lindahl from DNB Markets. Please provide the JSON document with the transcript that needs to be edited.

Unknown 1
28:14 - 28:17

Hello, Peter. And credit. Thanks for taking my questions.

Fredrik Nilsson
28:17 - 28:18

I wanted to.

Unknown 3
28:18 - 28:44

Come back to the medical business. Uh, the destocking there. I guess you are now under the impression that this has been finalized. Meaning the exit rate out of the quarter must have been much stronger than you had anticipated previously. And how should we sort of frame that in heading into the next quarter or the second half of this year, thinking about the growth for the medical business? That's my first question.

Peter Nilsson
28:45 - 30:12

Yeah, I mean, it's difficult to guide, to be honest, for August, because it's, let's say, individual call-ups with a limited number of customers in a way, which is driving this. We feel that the majority of customers are now moving into the group. Right again. But there are still some customers who continue this discussion. So it's kind of a turning point. And that is why, honestly, it's difficult for us to provide you with firm guidance. We don't really know ourselves, and we need to closely follow the demands of the customers, as there was a substantial increase in their revenues. So, we have to make the best estimate here and exercise our judgment. And we are at our best estimate, expecting it to improve from what we observed in Q2. But I mean, we cannot say that we are fully confident about that one. We need to examine the figures, make our best judgment, and then be open about what we believe. Currently, we believe that it will increase from these 2%, but I cannot precisely predict when it will reach 4, 6, or 8%. I don't know, but we do see potential. It's going to get better. I mean, that is really what we see. I'm sorry, I can't do any better than what I'm currently trying.

Unknown 4
30:12 - 30:14

No, that's fine.

Unknown 3
30:14 - 30:24

I'm just trying to say it's a new business for all of us. To some extent. I'm just trying to understand what the visibility really is here on your backlog.

Peter Nilsson
30:24 - 30:44

We have a good backup. We have a good backlog. You have to say the business is running. We have a good backlog. We receive frame orders, and then they initiate call-offs. And that is because call-offs are something that we cannot really control. So, that is where it's happening. But once again, we are feeling that this is really exciting, especially in terms of inventory reductions.

Unknown 3
30:46 - 31:06

Thanks.

Peter Nilsson
31:08 - 32:18

We still have solid growth. Let's say we talk about 10% plus organic growth in this area. And I mean, it could have been even better if, uh, everyone was able to deliver and there were no Boeing-related problems or anything of that sort. But I mean, it's really. It's performing really well, with the order book growing even more. The Airbus order book is very strong. The Boeing order book is also very strong. Of course, Boeing has well-known challenges. But beyond those challenges, they still have a very firm order book. So we don't see any say. The sales growth for us is more in terms of what the customers can actually absorb, because the order books of the customers are growing. Our order book is growing. And I mean, it's still looking very good. If we look at the medium term, long term, or short term. So, there's really a good amount everywhere. It's more a matter of what you're able to supply and what the customer is able to absorb.

Unknown 3
32:19 - 32:32

And then a final question from my side, looks like your performance from a cyclic standpoint is quite strong, I would say. And would you claim that you're gaining market share in certain products or segments?

Peter Nilsson
32:33 - 33:34

I think we've been working hard in the areas we discussed, particularly in investing in growth. And of course, that is also driven by a mix. And that is something that we are. Yeah. Getting payback on that one that we have been investing in certain areas. We are progressively shifting our focus to become increasingly active in areas with robust growth rates, and that is where we see the benefits. So what I mean is, it's not really one individual action; it's a lot of actions. We were driving this through our Speedboat initiative. And we believe that we are now seeing the first signs of those benefits. And of course, continue to invest in these areas to improve. And then we have some specific segments where we have been doing very well. Indeed, we have some automotive businesses performing well. We have some niches in aerospace doing well. Overall, it's been satisfactory.

Unknown 1
33:35 - 33:36

Yes.

Peter Nilsson
33:36 - 33:44

So, we feel satisfied with the overall mix changes. Currently, we are addressing labor issues.

Unknown 4
33:45 - 33:46

Okay.

Unknown 3
33:46 - 33:47

Thank you very much. That's it for me. Thank you.

Operator
33:51 - 33:57

The next question comes from Eric Gurung from Seb. Please go ahead.

Unknown 5
34:02 - 34:19

Thank you. I have one question. It concerns the solutions. We achieved 5% organic growth in the quarter. Margins are still coming down slightly due to the growth investments you mentioned. What kind of growth do we need to see for these investments to be fully absorbed? That's my question.

Peter Nilsson
34:20 - 36:20

Yes, hopefully, we are about to turn the corner. I mean, we are entering a growth phase, as you mentioned. Also, despite the growth this quarter, some volume segments remain depressed. I mean, we're talking about sectors like fluid power, pneumatics, and hydraulics, which involve a lot of manufacturing volume that is still somewhat depressed. We are focusing on improving the mix in sealing solutions, although we don't yet see it reflected in the margins because we have decided not to reduce operations fully in some of these core segments, believing they will rebound. We remain confident that as these large volume segments begin to recover, which we are now starting to see, Hopefully, we will experience a double benefit, where we simultaneously achieve a good mix and high volumes in quality segments. This is primarily a manufacturing mix issue, still prone to some underabsorption in certain manufacturing facilities, which we intentionally maintain to be prepared for future growth. But we are approaching a turning point in this regard. We are also starting to see the benefits of MRP in terms of sales, albeit gradually. Although we have guided that this is not expected to happen until next year. We are still carrying extra manufacturing capacity and resources to be prepared for the anticipated growth. We are not focusing on individual quarters here. We are working to create long-term, superior sealing solutions, and we remain confident that we will achieve this quickly as volumes return.

Unknown 5
36:22 - 36:22

Okay.

Unknown 1
36:22 - 36:23

Thank you.

Operator
36:28 - 36:34

The next question comes from Agnieszka Villella from Nordica. Please go ahead.

Unknown 6
36:36 - 36:53

Perfect. Thank you. Um, my first question. I think it's probably for Fredrik, when we sum the other operating income and expenses, they're quite negative in the quarter, close to -90 million. Can you say if there is anything specific driving those costs?

Fredrik Nilsson
36:55 - 37:10

No, it's nothing out of the ordinary. It's, uh, you know, we are reporting, uh, effects. Uh, plus and minus about as income and costs. So it's just the normal items that you have in that line in the quarter.

Unknown 6
37:12 - 37:33

Great. Thank, you. And then on the gross margin in the quarter, it was at 37%, up by almost three percentage points year on year. Can you, Frederick, explain what's driving the profitability improvement in the quarter despite limited organic growth?

Fredrik Nilsson
37:36 - 37:59

No, but it's a combination. You said organic growth is helping. There is also a good mix. We are growing in some right segments with good profitability. Uh, so I would say that there is nothing specific. I mean, it's just that, uh, operational improvements over a long time that are starting to pay off.

Unknown 6
38:00 - 38:14

Perfect. Thank you. And in the automotive industry, we still see quite good growth. But, looking at the car production, it seems to be slowing down a bit. So can you explain what's driving the growth specifically for you in that segment?

Peter Nilsson
38:15 - 39:46

Well, I mean, I have to be honest, we are surprised. We didn't expect this volume to continue. What we see is continuing here going into the next quarter. There are a few drivers. We have a good aftermarket for our braking business that we have within sealing solutions. We have a few new products in terms of sensors and various automation devices in cars. So we have a few areas there. We're driving it. We're also achieving good market share gains in industrial solutions in this activity area. I remember when we bought a small boots business that we had there. We made a small but very interesting acquisition in India, which created a new kind of global footprint for us. We are gaining market share in that area, being the only one able to offer fully global support. So, there are a few special small niches where we're doing very well. But overall, as you know, there is a misalignment between the overall car growth and our sales growth. We do not expect it to continue, but it looks good, at least for the next quarter. We expect this for a few quarters. Honestly, we have been surprised by the demand in this segment for us.

Unknown 6
39:47 - 40:06

Great. And just the last one for me, I wonder if you will be helping us with the numbers for Baron later on, maybe providing historical quarterly development for them. So we understand the seasonality. Right. Will you be disclosing that at all or not?

Peter Nilsson
40:06 - 40:16

Not the individual data for Baron. No, because this is being integrated with synergies. So, you're going to get only the full integrated profitability for medical solutions.

Unknown 6
40:17 - 40:17

Okay, thank you.

Operator
40:23 - 40:29

The next question comes from Timothy Lee from Barclays. Please go ahead.

Unknown 3
40:31 - 40:31

Hi.

Unknown 7
40:31 - 41:00

Thanks for taking my questions. The first question is just a little bit of follow-up on the medical solutions business. Can you describe the exact reason why the performance in the later part of the quarter was substantially improving? Or, was that due to stocking activities by some of the customers happening later in the quarter? Is there a particular reason driving that outperformance? Any details would be helpful.

Peter Nilsson
41:00 - 43:07

You know, we have a few customers that actually ordered more. Our strategy for medical solutions is to target larger customers, which means fairly sizable accounts. And of course, that leads them to order a little bit more. It's noticeable in the sales. We cannot highlight any specific team. It's really that we had a bunch of customers who started to order more than expected, and based on their information, they are now running out of stock and need to replenish. This is not happening with all customers. We still have some customers who are indicating that their inventory levels remain somewhat high, but we do see that some customers are now running out of stock and have started to buy again. I mean, that is really the comment, so it's really difficult to highlight certain areas. Of course we know the customers, we know which customers are buying, but we don't really want to highlight them in a call like this. But we note that the view is not one customer’s; a few customers have started to buy again at levels which they were buying a year ago. And I mean, of course we know that I've been destocking. Of course, we're looking at their sales level compared to inventory and other factors. And we know that certain big medical companies are probably approaching the end of their inventory reduction cycle. But once again, while there are still a few customers, we are overstocked. But we have to consider the diverse mix of customers. And if we touch on the big mix of customers, we do this overall evaluation that they are easing the stock focus and starting to buy more in line with their actual consumption. And that is what we have been benefiting from here, especially during June, which we see also continuing into the next quarter for these customers.

Unknown 7
43:10 - 43:38

Thank you. In the third quarter or in the second half of the year. For Industrial Solutions, as mentioned in the quarterly report, there could be a positive sales mix to drive the margin improvement. Is that something noteworthy, you know, structurally improving your mix in the segment to drive the margin?

Peter Nilsson
43:39 - 44:44

In the solutions, I think there was some confusion here going into the quarter. And that's not happening this year. So, I don't think you should extrapolate that the margin in Industrial Solutions will be a challenging target to meet, compared to the margin target from a year ago, since I do not have this information. Do not read into this as there being a major deterioration. However, meeting their individual margin targets for Q3 will be a challenge for them. Of course, we're doing our best and we are working towards it, but it's going to be a tough comparison for Industrial Solutions in Q3 due to the extraordinary order we had a year ago, which we commented on. At that time.

Unknown 7
44:46 - 45:20

I just understood. And then for the sealing solutions, as you mentioned earlier, you're also waiting for some of these volume segments to improve in the drive to the segment margin. And you also mentioned that the synergy from the MNE Group acquisition will be mainly in 2025, in your report. This will mean that the segment margin is likely to be more or less flattish in the rest of the year before we see some big improvements in 2025.

Peter Nilsson
45:21 - 46:12

I mean, we are always working here, let's say. I mean, we have been stating that we'd be aiming for a higher margin within Sealing Solutions, and we say that we're going to achieve this target margin by the end of 2025. So of course, we do expect some slight improvement there going forward. We don't want to guide for individual quarters, but of course, we are in order to reach our long-term targets. But I mean, it's not really difficult; we just don't want to give, let's say, firm guidance on individual quarters or individual six-month periods. But of course, we are not working for individual quarters. We are working towards long-term improvements. And that is the direction we are heading.

Unknown 4
46:14 - 46:15

Right? Exactly.

Unknown 7
46:16 - 46:17

So helpful. Thank you.

Operator
46:24 - 46:30

The next question comes from Hampus Angulo from Handelsbanken. Please go ahead.

Unknown 8
46:31 - 46:49

Thank you very much. Two questions from me. Peter, could you quantify the impact of Easter on the second quarter? Just to understand if there are any deviations between the business areas.

Peter Nilsson
46:49 - 46:52

We would clarify them for you. Yes, sorry.

Unknown 8
46:52 - 46:53

Go ahead, go ahead.

Peter Nilsson
46:53 - 47:42

The Easter effect primarily affects the number of working days and such, mainly impacting Sealing Solutions. It doesn't really affect Industrial Solutions, which is more related to product-based sales and is not impacted. So, we would say a 1 to 2% movement in organic growth from Q1 to Q2. That is what we are discussing. You would then perform a mathematical calculation. But that is essentially it. So, the growth in this quarter is perhaps 1 to 2 percentage points too high, and it was too low in Q1 for Sealing Solutions. However, for the rest of the group, we don't see it being impacted by Easter as it is in Sealing Solutions.

Unknown 8
47:44 - 47:58

Fredrik, regarding George's full-year guidance, I understand that it does not include anything from Baron Group and it's perhaps too early. Should we expect to look at that for maybe the first half of next year? How should we think about that?

Fredrik Nilsson
47:58 - 48:04

That's correct. All the guidance excludes Baron Group.

Peter Nilsson
48:05 - 48:30

However, we do not anticipate any major costs from Baron because it represents a strategic move for us. We are utilizing existing capabilities and gaining benefits from joint purchasing and some insourcing of tooling and such. So, that is unremarkable. We shouldn't expect any costs from extracting synergies from Baron Group.

Fredrik Nilsson
48:31 - 48:40

No, the only way we will see a change in the guidelines will be when we have done the PPA calculation, because then, of course, some motivation will go up.

Unknown 1
48:40 - 48:42

Mm mm.

Unknown 8
48:42 - 48:54

And also for, to really clarify here, when you talk about consolidating, will that be fully consolidated? So as of the third quarter, will it be two months or the entire quarter?

Fredrik Nilsson
48:55 - 49:00

It will be one and a half months. It will be consolidated from yesterday.

Peter Nilsson
49:00 - 49:01

As of yesterday.

Unknown 4
49:02 - 49:03

Okay, so we have a.

Peter Nilsson
49:03 - 49:11

We have a mid-month closing, where we are getting it sorted out. So we actually have owned it fully from as of yesterday.

Fredrik Nilsson
49:11 - 49:24

Yes. And also, to clarify, the payment to Baron has also been made yesterday. So, it's not included in the net debt by the end of Q2, just to make that clear as well.

Unknown 8
49:25 - 49:26

Excellent. Thank you.

Operator
49:34 - 49:50

As a reminder, if you wish to ask a question, please dial the pound key five on your telephone keypad. There are no more questions at this time, so I hand the conference back to the speakers for any closing comments.

Peter Nilsson
49:52 - 50:41

Thank you, and thanks to all of you for showing interest in Trelleborg and how we perform. And of course, I'm available. Fredrik is available. And also, Christopher is very much available for any kind of follow-up questions. Happy to support you in any way we can to enhance your understanding of Trelleborg as we continue to develop the company and drive it toward even better margins, returns, and growth. And looking forward, speaking to you again hopefully soon and if not soon, then we will for sure touch base here in the next few months. So do take care and all the best to all of you.

Continue to the webcast
Pierce Group, Audiocast, Q3'26
Language: English11/13/2026, 8:00 AM
Göran Dahlin Good morning, everyone, and welcome to Pierce Group's presentation of our Q3 2026 interim results. Next slide, please. I am Göran Dahlin, CEO of Pierce Group, and I am with Fredrik Kjellg…
Surgical Science Sweden, Audiocast, Q3'26
Language: English11/12/2026, 10:00 AM
Tom Englund Hi everyone, and welcome to this earnings call for Surgical Science for the third quarter of 2026. My name is Tom Englund. I am the CEO. And with me today is our CFO, Anna Ahlberg. I wil…
ExpreS2ion Biotech – Presentation of Q3 2026 Interim Report
Language: English11/12/2026, 9:00 AM
ExpreS2ion is expected to release its Q3 2026 interim report on 12 November 2026. Later the same day at 10.00, ExpreS2ion’s CEO Bent U. Frandsen and CFO Keith Alexander will present the results and answer questions in a live online event.
Meko Services AB, Q3'26
Language: English11/12/2026, 8:00 AM
Pat Thank you. Good morning, and welcome to MEKO's presentation of the third quarter of 2026. I am here with our CFO, Christy Johansson, and I will begin with an overview of the quarter and some of th…
WeSports Group, Audiocast, Q3'26
Language: English11/12/2026, 8:00 AM
Unknown 1 It. Ted Sporre Welcome to our Q3 release presentation. As you know, we have already shared preliminary figures for sales and EBITDA for this quarter, but today we complete the picture. We wi…
Nordrest Holding, Audiocast, Q3'26
Language: Swedish11/12/2026, 8:00 AM
Thomas Dahlstedt Hej och välkomna! Vi ska idag presentera Nordrests senaste kvartal och tillika resultatet för perioden. Jag som pratar nu heter Thomas Dahlstedt och är grundare och tillika VD för bol…
Karnov Group, Audiocast, Q3'26
Language: English11/12/2026, 8:00 AM
Pontus Bodelsson Welcome, everyone, to Karnov Group's earnings conference, where we will present the outcome of the third quarter of 2026. Please go to slide two. I am Pontus Bodelsson, President and…
Fasadgruppen Group, Audiocast, Q3'26
Language: English11/12/2026, 7:15 AM
Magnus Blomberg Perfect. Good morning and welcome to the Fasadgruppen presentation of our results for the third quarter 2026. My name is Magnus Blomberg. You have met me before. I am the CFO of Fasadg…
Munters AB, CMD
Language: English11/11/2026, 1:00 PM
Lena Dauvergne Good. Good afternoon everyone, and a warm welcome to Stockholm, to ESSEX and to Montage Capital Markets Day 2026. Montage Capital Markets Day 2026. It is really good to see so many of y…
Cinclus Pharma, Audiocast, Q3'26
Language: English11/11/2026, 1:00 PM
Christer Ahlberg Thank you. Hello and welcome to the Cinclus Pharma third quarter 2026 earnings call. I am Christer Ahlberg, CEO of Cinclus Pharma, and with me today is our CFO, Magnus Christensen. We…
Proact IT, CMD
Language: English11/11/2026, 12:30 PM
Unknown 1 The world of data is constantly changing. Breaches are rising, and attacks are getting more advanced. Regulation drives the need for data sovereignty. Data has to be available. Critical busi…
Ferronordic AB, Audiocast, Q3'26
Language: English11/11/2026, 9:00 AM
Henrik Good morning, everyone, and welcome to our presentation of the third quarter of 2026. During the quarter, we saw higher earnings, and growing aftermarket revenue was up 15% to 1.2 billion Swedi…
BICO, Audiocast, Q3'26
Language: English11/11/2026, 9:00 AM
Anders Fogelberg Good morning, everyone, and welcome to BICO's earnings call for the third quarter of 2026. I am Anders Fogelberg, President and CEO of BICO. And joining me today is our Group CFO, Ewa…
Catena Media, Audiocast, Q3'26
Language: English11/10/2026, 5:00 PM
Manuel Stan Good afternoon. Good evening, everyone. Welcome to the Catena Media Q3 Interim Report. I am Manuel Stan and today I'm joined by our Chief Financial Officer, Michael Gerrow. Today we will b…
Ellos Group, Q3'26
Language: English11/10/2026, 8:00 AM
Hans Ohlsson Live. Good morning, everyone, and welcome to the second presentation for Ellos Group as a listed company. We have 45 minutes today for the presentation. And there is a hard stop. After th…
Scandic Hotels Group, Audiocast, Q3'26
Language: English11/10/2026, 8:00 AM
Jens Mathisen Thank you so much, and good morning, everyone, and thank you for joining us for the Q3 presentation. I am Jens Mathisen, CEO of Scandic. And joining me is our CFO, Pierre Carstensen. We…
Svevik Industri, Q3'26
Language: Swedish11/6/2026, 9:00 AM
Johan Hårdén Tack så mycket! Hello and welcome to this hearing regarding the Q3 2026 interim report. We have an agenda where we intend to introduce ourselves to all the new shareholders as well. Kort…
Attendo, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
Martin Tivéus Good morning, everyone, and thank you for joining us. Today, we will present our results for the third quarter of 2026. I am pleased to announce that this is the strongest quarter for At…
Cavotec, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
David Pagels Good morning and welcome to Cavotec's Q3 2026 presentation. I am David Pagels, the CEO of Cavotec. And together with me today, I have our new CFO, Christoffer Robertsson. I would like to…
Fractal Gaming Group, Audiocast, Q3'26
Language: English11/6/2026, 9:00 AM
Jonas Good morning, everyone, and welcome to Fractal's Q3 2026 presentation. Today, we'll take you through our results, the progress that we've made, and our priorities ahead after a difficult first h…